BOV Stock Overview
An energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Apyx Medical Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.30 |
| 52 Week High | US$1.75 |
| 52 Week Low | US$0.71 |
| Beta | 1.12 |
| 1 Month Change | 66.67% |
| 3 Month Change | -2.26% |
| 1 Year Change | -8.45% |
| 3 Year Change | -74.76% |
| 5 Year Change | -66.84% |
| Change since IPO | -77.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| BOV | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 6.6% | -1.2% | 0.5% |
| 1Y | -8.5% | -11.8% | 15.8% |
Return vs Industry: BOV underperformed the German Medical Equipment industry which returned -11.5% over the past year.
Return vs Market: BOV underperformed the German Market which returned 16.5% over the past year.
Price Volatility
| BOV volatility | |
|---|---|
| BOV Average Weekly Movement | 20.1% |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in DE Market | 12.8% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: BOV's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: BOV's weekly volatility has increased from 14% to 20% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 220 | Charlie Goodwin | apyxmedical.com |
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures.
Apyx Medical Corporation Fundamentals Summary
| BOV fundamental statistics | |
|---|---|
| Market cap | €55.23m |
| Earnings (TTM) | -€17.64m |
| Revenue (TTM) | €41.63m |
Is BOV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BOV income statement (TTM) | |
|---|---|
| Revenue | US$47.29m |
| Cost of Revenue | US$18.21m |
| Gross Profit | US$29.08m |
| Other Expenses | US$49.11m |
| Earnings | -US$20.04m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.53 |
| Gross Margin | 61.49% |
| Net Profit Margin | -42.37% |
| Debt/Equity Ratio | 320.6% |
How did BOV perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/23 22:42 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Apyx Medical Corporation is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Gorman | BTIG |
| Sam Eiber | BTIG |
| David Turkaly | Citizens JMP Securities, LLC |